Sitewide
Melanoma drug revs immune cells but cancer cells ignore it
A new study shows that an important drug used in the treatment of malignant melanoma has little effect on the melanoma cells themselves. Instead, it activates immune-system cells to fight the disease. The drug, called interferon alpha, is used to clean up microscopic tumor cells that may remain in the body following surgery for the disease. It is the only drug approved for this purpose.
Similar Articles On This Topic:
- Interferon Alpha (IFNa) revs immune cells but cancer cells ignore it
- Relatives of melanoma patients ignore their skin cancer risk
- Drug therapy to bolster immune system cells found effective toward childhood cancer
- A leukemia drug kills cancerous T-cells while sparing normal immunity
- To promote lasting impact, cancer drugs should force dying cells to alert immune response
Popular Today:
Science 2.0:
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment